Archives
-
2',7'-Dichlorofluorescein diacetate for ROS
2026-09-22
Build a practical intracellular ROS measurement workflow for microscopy, flow cytometry, and plate assays using a broadly responsive fluorescent probe. The guide also shows how redox readouts can support evaluation of ROS-responsive nanocarriers in pancreatic cancer models without overstating probe specificity.
-
Central Control of Opioid Mechanical Hypersensitivity
2026-09-22
A 2024 Neuron study identifies a brain-to-spinal µ-opioid receptor pathway that links repeated morphine exposure to mechanical hypersensitivity and analgesic tolerance in mice. Its circuit-level evidence separates mechanical pain consequences from better-characterized thermal effects and provides a framework for testing receptor-selective interventions in opioid receptor signaling research.
-
Dual SMAD/Wnt Inhibition for iPSC-RGC Differentiation
2026-09-21
The reference study presents a chemically defined strategy that combines SMAD and canonical Wnt inhibition to produce retinal ganglion cells from induced pluripotent stem cells with improved yield and reproducibility. The workflow generated retinal ganglion cell populations exceeding 80% purity and increased enrichment to nearly 95% using CD90.2-based magnetic sorting, offering a practical foundation for glaucoma modeling and retinal neurobiology.
-
GCG Disrupts SARS-CoV-2 Nucleocapsid Condensation
2026-09-21
The reference study identifies RNA-triggered liquid–liquid phase separation by the SARS-CoV-2 nucleocapsid protein as a mechanistic step in viral organization and replication. It further shows that (-)-gallocatechin gallate disrupts N–RNA condensation and suppresses viral replication, providing a framework for studying antiviral intervention at biomolecular condensates.
-
HyperFusion high-fidelity DNA polymerase for PCR
2026-09-20
HyperFusion™ high-fidelity DNA polymerase combines proofreading accuracy, speed, blunt-end generation, and inhibitor tolerance for difficult C. elegans PCR targets. This workflow-oriented guide shows how to apply it to genotyping, cloning, and sequencing studies inspired by pheromone-driven neurodegeneration research.
-
Ibuprofen A8446 for Reliable Cell Assays
2026-09-19
Learn how Ibuprofen (SKU A8446) can support more consistent cell viability, proliferation, apoptosis, and cell-cycle workflows. This scenario-based guide covers mechanism, solvent compatibility, protocol design, data interpretation, and practical vendor-selection criteria.
-
EMD638683 SGK1 Inhibitor Workflows
2026-09-18
Use EMD638683 to connect SGK1 pathway engagement with endothelial stiffness, actin remodeling, NDRG1 phosphorylation, and tumor-cell responses. This practical guide covers dosing, controls, solubility, assay selection, and the limits of translating an SGK1 inhibitor across cardiovascular and cancer models.
-
13-Benzyl Berberine Derivatives as Antifungals
2026-09-18
The 2006 study by Park and colleagues developed 13-(substituted benzyl) berberine and berberrubine derivatives to improve activity against human pathogenic fungi. Aromatic substitution at the 13-position produced a clear structure–activity relationship, with 13-(4-isopropylbenzyl) berberine showing the strongest activity against Candida species and outperforming its berberrubine analogue.
-
RSL3: GPX4 Inhibitor for Ferroptosis Research
2026-09-17
RSL3 is a glutathione peroxidase 4 inhibitor used to induce ferroptosis through oxidative stress and lipid peroxidation. Product information and peer-reviewed studies support its use in ferroptosis research, RAS-mutant cancer models, and mechanistic studies of tumor-cell redox vulnerability.
-
Tropifexor Protects the Neonatal Intestinal Barrier
2026-09-17
A 2025 FASEB Journal study shows that the FXR agonist Tropifexor improves intestinal defense responses and epithelial barrier integrity in neonatal piglets receiving parenteral nutrition. By combining a neonatal minipig model, transcriptomics, and patient-derived organoids, the work connects FXR activation with EPCAM-associated barrier protection and provides a translational framework for intestinal injury research.
-
Octenidine Dihydrochloride: Mechanism & Research Use
2026-09-16
Octenidine dihydrochloride is a cationic antiseptic small molecule used as an antimicrobial agent for research. Its principal research value is membrane disruption, while product handling, assay conditions, cytotoxicity, and the distinction between laboratory evidence and clinical use determine how results should be interpreted.
-
Phosphatase Inhibitor Cocktail 2: Workflow Guide
2026-09-16
Protect phosphorylation-dependent readouts from harvest-time artifacts in cell and tissue extracts. This practical guide connects broad phosphatase control with Western blotting, interaction assays, kinase measurements, and the SIRT6–proteostasis research context.
-
Dasatinib Monohydrate for CML Research
2026-09-15
Dasatinib Monohydrate enables controlled studies of BCR-ABL signaling, imatinib-resistant leukemia models, and kinase-dependent effects on neutrophil extracellular traps. This practical workflow combines solvent-aware dosing, orthogonal leukemia readouts, and NET assay controls to improve reproducibility.
-
Doxycycline Hyclate: MMP Assay Design Guide
2026-09-15
Explore how Doxycycline hyclate functions as a matrix metalloproteinases inhibitor and how a mouse BBB study informs rigorous assay design. This guide connects mechanism, controls, handling, and cross-domain limitations for reproducible research.
-
Molecular Basis of TRPM3 Modulation
2026-09-14
Yin and colleagues define how pregnenolone sulfate, the synthetic agonist CIM0216, and the anticonvulsant primidone interact with TRPM3 using cryo-electron microscopy, electrophysiology, molecular dynamics, and biochemical analysis. The study links distinct ligand-binding sites to channel gating and disease-associated gain-of-function mutations, providing a structural framework for TRPM3 pharmacology in pain and neurodevelopmental disorders.